FDA Approved: ATIVAN — Supplemental Application (Bausch Health US LLC)

View source ↗

Summary

The FDA approved a supplemental application for ATIVAN (lorazepam) submitted by Bausch Health US LLC, resulting in a labeling change for the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety Disorders
• Epilepsy
• Insomnia

Drugs mentioned

• Ativan (Lorazepam)

Snippet

SUPPL AP for ATIVAN (LORAZEPAM)